Alzheimer’s Breakthrough Targets Genes That May Raise Risk up to 12 Times
Summary
Researchers at the University of Bristol converted the high-risk APOE4 gene into APOE3 in human immune cells from people with Alzheimer’s who carried two APOE4 copies. The experimental work found little effect on nearby DNA and is an early step toward exploring whether gene editing could reduce Alzheimer’s risk.Key Facts
- The team used engineered enzymes to make precise changes to DNA.
- The researchers tested the approach in human immune blood cells from people with Alzheimer’s who had two APOE4 copies.
- The team converted APOE4 into APOE3 in those cells.
- Researchers observed little impact on surrounding DNA.
- About one in four people carry an APOE4 variant.
- People with two APOE4 copies may be eight to 12 times more likely to develop Alzheimer’s than people with two APOE3 copies.
- The project began with a one-year pilot study funded by the Bristol-based charity BRACE Dementia Research.
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.